Wall Street brokerages predict that HealthStream, Inc. (NASDAQ:HSTM) will announce $61.24 million in sales for the current fiscal quarter, Zacks Investment Research reports. Five analysts have issued estimates for HealthStream’s earnings, with the lowest sales estimate coming in at $60.30 million and the highest estimate coming in at $62.14 million. HealthStream posted sales of $54.79 million during the same quarter last year, which suggests a positive year-over-year growth rate of 11.8%. The company is expected to announce its next quarterly earnings results on Monday, July 24th.
On average, analysts expect that HealthStream will report full year sales of $61.24 million for the current fiscal year, with estimates ranging from $249.50 million to $253.20 million. For the next financial year, analysts forecast that the business will report sales of $280.62 million per share, with estimates ranging from $275.70 million to $288.75 million. Zacks Investment Research’s sales averages are an average based on a survey of research analysts that that provide coverage for HealthStream.
HealthStream (NASDAQ:HSTM) last released its quarterly earnings results on Monday, April 24th. The technology company reported $0.04 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.03 by $0.01. HealthStream had a return on equity of 1.93% and a net margin of 1.53%. The firm had revenue of $59.90 million for the quarter, compared to the consensus estimate of $59.25 million. During the same quarter last year, the business posted $0.05 EPS. The company’s revenue for the quarter was up 10.7% on a year-over-year basis.
Several brokerages have issued reports on HSTM. Cantor Fitzgerald increased their target price on shares of HealthStream from $27.00 to $30.00 and gave the stock a “neutral” rating in a report on Monday, May 1st. Zacks Investment Research upgraded shares of HealthStream from a “sell” rating to a “hold” rating in a report on Tuesday, April 25th. Craig Hallum upgraded shares of HealthStream from a “hold” rating to a “buy” rating in a report on Tuesday, April 25th. Needham & Company LLC increased their target price on shares of HealthStream from $28.00 to $32.00 and gave the stock a “buy” rating in a report on Wednesday, April 26th. Finally, Robert W. Baird set a $31.00 target price on shares of HealthStream and gave the stock a “buy” rating in a report on Tuesday, April 25th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $27.11.
HealthStream (HSTM) traded up 1.67% during mid-day trading on Friday, hitting $29.88. The company’s stock had a trading volume of 205,593 shares. The firm has a market cap of $952.63 million, a price-to-earnings ratio of 271.64 and a beta of 1.12. The firm has a 50 day moving average of $28.79 and a 200-day moving average of $25.21. HealthStream has a 52-week low of $20.60 and a 52-week high of $30.08.
TRADEMARK VIOLATION WARNING: This news story was originally posted by WKRB News and is owned by of WKRB News. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international trademark and copyright law. The legal version of this news story can be accessed at https://www.wkrb13.com/markets/2231129/healthstream-inc-hstm-expected-to-post-quarterly-sales-of-61-24-million.html.
Hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its stake in HealthStream by 4.8% in the first quarter. Vanguard Group Inc. now owns 2,235,738 shares of the technology company’s stock worth $54,172,000 after buying an additional 102,888 shares in the last quarter. Conestoga Capital Advisors LLC boosted its stake in HealthStream by 6.2% in the first quarter. Conestoga Capital Advisors LLC now owns 1,448,317 shares of the technology company’s stock worth $35,093,000 after buying an additional 84,308 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in HealthStream by 1.5% in the first quarter. Dimensional Fund Advisors LP now owns 1,165,088 shares of the technology company’s stock worth $28,230,000 after buying an additional 17,739 shares in the last quarter. Pembroke Management LTD boosted its stake in HealthStream by 7.0% in the first quarter. Pembroke Management LTD now owns 1,121,028 shares of the technology company’s stock worth $27,162,000 after buying an additional 73,700 shares in the last quarter. Finally, Janus Capital Management LLC boosted its stake in HealthStream by 153.8% in the first quarter. Janus Capital Management LLC now owns 886,282 shares of the technology company’s stock worth $21,475,000 after buying an additional 537,116 shares in the last quarter. Institutional investors and hedge funds own 77.35% of the company’s stock.
HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2231129/healthstream-inc-hstm-expected-to-post-quarterly-sales-of-61-24-million.html
Receive News & Ratings for HealthStream Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream Inc. and related companies with MarketBeat.com's FREE daily email newsletter.